Dr Ally Prebtani, professor of medicine in the Division of Endocrinology and Metabolism at McMaster University, discusses the recently published meta-analysis of the use of SGLT-2 inhibitors and GLP-1 receptor agonists in diabetes.
Dr Gordon Guyatt, distinguished professor in the Department of Health Research Methods, Evidence, and Impact at McMaster University, discusses the latest findings on tocilizumab in the treatment of COVID-19.
Dr Bram Rochwerg, associate professor in the Division of Critical Care and lead author of the WHO/BMJ COVID-19 practice guidelines, discusses the most recent WHO recommendations on remdesivir use.
Dr Jean-Louis Vincent, professor of intensive care medicine at Université libre de Bruxelles and past president of the World Federation of Societies of Intensive and Critical Care Medicine, comments on the current treatment options in COVID-19.
Dr Jean-Louis Vincent, professor of intensive care medicine at Université libre de Bruxelles and past president of the World Federation of Societies of Intensive and Critical Care Medicine, discusses the epidemiologic situation in Belgium and current standards of care for ICU patients with COVID-19.
Dr Mark Loeb, professor in the Department of Pathology and Molecular Medicine at McMaster University, joins Dr Roman Jaeschke to clarify the difference between droplets vs aerosols and surgical masks vs N95 respirators.
Dr Dominik Mertz, associate professor in the Division of Infectious Diseases at McMaster University and medical director of infection prevention and control at Hamilton Health Sciences, talks about COVID-19 vaccines, reopening schools, and air travel during the pandemic.
Dr Dominik Mertz, associate professor in the Division of Infectious Diseases at McMaster University and medical director of infection prevention and control at Hamilton Health Sciences, talks about the current COVID-19 situation worldwide.
Dr Harriette Van Spall, associate professor in the Division of Cardiology at McMaster University, scientist at the Population Health Research Institute, and cardiologist at Hamilton Health Sciences, puts in context some of the most impactful heart failure clinical trials of recent years.
Dr Harriette Van Spall, associate professor in the Division of Cardiology at McMaster University, scientist at the Population Health Research Institute, and cardiologist at Hamilton Health Sciences, discusses the evolution of vasodilators used in heart failure treatment.
English
Polski
Español
українська